Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA
Akihiro Kagita1, Mandy S Y Lung1, Huaigeng Xu1
1Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Stem Cell Reports
|March 12, 2021
Summary
Intracellular RNA inhibits CRISPR-Cas9 genome editing. Precomplexing Cas9 and sgRNA significantly boosts editing efficiency, enabling high-frequency single-nucleotide corrections and allele replacement in iPSCs.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- CRISPR-Cas9 and ssODNs enable targeted genomic alterations in iPSCs.
- Low ssODN knockin frequency limits precise genome editing.
- The biochemical behavior of Cas9 in mammalian cells remains underexplored.
Purpose of the Study:
- Investigate intrinsic cellular factors affecting Cas9 cleavage activity.
- Identify methods to enhance CRISPR-Cas9 genome editing efficiency.
- Optimize conditions for high-frequency ssODN knockin and allele replacement.
Main Methods:
- In vitro assays to assess Cas9 cleavage activity.
- Analysis of intracellular RNA, DNA, and protein fractions.
- Precomplexing Cas9 and sgRNA into ribonucleoprotein (RNP) complexes.
- Optimizing electroporation parameters for RNP and ssODN delivery.
- Generating custom-edited iPSCs by replacing HLA alleles.
Main Results:
- Intracellular RNA inhibits Cas9 binding to sgRNA and reduces enzymatic activity.
- Precomplexing Cas9-sgRNA (RNP) before cell delivery enhances genome editing compared to overexpression.
- Optimized electroporation achieved up to 70% single-nucleotide correction and 40% loxP insertion.
- Successful replacement of HLA-C1 with HLA-C2 alleles in iPSCs.
Conclusions:
- Intracellular RNA is a key inhibitor of Cas9 activity.
- Cas9-sgRNA RNP complex formation and optimized delivery are crucial for efficient genome editing.
- This optimized method significantly improves precise genome engineering in iPSCs, including allele replacement.
Keywords:
CRISPR-Cas9Cas9 inhibitionCre-loxP recombinationSNPgenome editinghomozygous correctioniPSCsingle nucleotide alterationMore Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
941
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
941
CRISPR
54.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
54.5K
siRNA - Small Interfering RNAs
17.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.6K
Experimental RNAi
6.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.8K
RNA Interference
27.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.1K


